IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 42 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $28,000 | -6.7% | 48,399 | +64.4% | 0.00% | – |
Q3 2021 | $30,000 | -11.8% | 29,447 | +1.2% | 0.00% | – |
Q2 2021 | $34,000 | -35.8% | 29,106 | -29.0% | 0.00% | – |
Q1 2021 | $53,000 | +140.9% | 41,000 | +304.1% | 0.00% | – |
Q3 2020 | $22,000 | -90.7% | 10,147 | -88.5% | 0.00% | – |
Q2 2019 | $237,000 | +507.7% | 88,608 | +522.0% | 0.00% | – |
Q4 2018 | $39,000 | – | 14,246 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 629,340 | $5,607,000 | 0.82% |
Baker Brothers Advisors | 4,833,897 | $43,070,000 | 0.28% |
Kassirer Asset Management Corp | 19,341 | $172,000 | 0.11% |
Virtus ETF Advisers LLC | 34,596 | $308,000 | 0.03% |
Palo Alto Investors LP | 77,044 | $686,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 147,560 | $1,280,000 | 0.03% |
ROPES WEALTH ADVISORS LLC | 12,500 | $111,000 | 0.03% |
Candriam S.C.A. | 195,000 | $1,737,000 | 0.02% |
NATIXIS | 429,816 | $3,830,000 | 0.02% |
Cordasco Financial Network | 1,875 | $17,000 | 0.02% |